Journal of Cataract & Refractive Surgery
Volume 33, Issue 9 , Pages 1539-1545, September 2007

In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac

From Keystone Research (Walters), Austin, Texas, private practices, Nacogdoches, Texas (Lehmann), Boston, Massachusetts (Raizman), and Warner Robins, Georgia (Gayton), and a surgical center (Ernest), Jackson, Michigan, USA

Accepted 22 May 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr. Raizman is a consultant to Alcon Laboratories, Inc. Drs. Walters, Ernest, Gayton, and Lehmann have received gifts in kind, honoraria, or travel reimbursement valued at over $1000 from Alcon Laboratories, Inc., in the past 12 months. No author has a financial or proprietary interest in any material or method mentioned.Financial support from Alcon Laboratories, Inc., Fort Worth, Texas, USA.

PII: S0886-3350(07)00991-1

doi:10.1016/j.jcrs.2007.05.015

Journal of Cataract & Refractive Surgery
Volume 33, Issue 9 , Pages 1539-1545, September 2007

Article Tools

* Image Usage & Resolution